Emerging BCL2 Inhibitors

被引：0
|
作者：
Anderson, Mary Ann [1 ,2 ,3 ,4 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic 3000, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic 3000, Australia
[3] Walter & Eliza Hall Inst Med Res, Div Blood Cells & Blood Canc, Melbourne, Vic 3000, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic 3000, Australia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
Venetoclax; small molecule inhibitors; apoptosis; BCL2; chronic lymphocytic leukemia; CHRONIC LYMPHOCYTIC-LEUKEMIA; PATIENTS PTS; LISAFTOCLAX APG-2575; ANTITUMOR-ACTIVITY; TARGETING BCL2; PHASE-I; VENETOCLAX; SAFETY; LYMPHOMA; MONOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S115 / S117
页数：3
相关论文
共 50 条
  • [1] BCL2 FAMILY INHIBITORS
    Dinardo, C.
    LEUKEMIA RESEARCH, 2023, 128
  • [2] Artemisinins enhanced the antileukemic efficacy of BCL2 inhibitors
    Moses, Blake S.
    Fox, Jennifer M.
    Chen, Xiaochun
    Tyner, Jeffrey W.
    Posner, Gary H.
    Bailey, Patrick
    Civin, Curt I.
    CANCER RESEARCH, 2017, 77
  • [3] The inhibitors of apoptosis: there is more to life than Bcl2
    Liston, P
    Fong, WG
    Korneluk, RG
    ONCOGENE, 2003, 22 (53) : 8568 - 8580
  • [4] The inhibitors of apoptosis: there is more to life than Bcl2
    Peter Liston
    Wai Gin Fong
    Robert G Korneluk
    Oncogene, 2003, 22 : 8568 - 8580
  • [5] BCL2 Inhibitors Target Diagnosed and Relapsed/Refractory AML
    Kontro, M.
    Majumder, M. M.
    Pemovska, T.
    Eldfors, S.
    Parsons, A.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Porkka, K.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 78 - 79
  • [6] BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
    Gupta, Vikas A.
    Ackley, James
    Kaufman, Jonathan L.
    Boise, Lawrence H.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2021, 11 : 11 - 24
  • [7] Novel BCL2 inhibitors with anti-lymphoma activity
    Mensah, Afua Adjeiwaa
    Chatzigiannis, Christos M.
    Diamantis, Dimitrios A.
    Gkalpinos, Vasileios K.
    Arribas, Alberto
    Tzakos, Andreas G.
    Bertoni, Francesco
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Induction of apoptosis and autophagy by small molecule BCL2 inhibitors
    Hickman, J.
    Geneste, O.
    Le Toumelin, G.
    Kroemer, G.
    Maiuri, C.
    Criollo, A.
    Rain, J. C.
    Gautier, F.
    Juin, P.
    BULLETIN DU CANCER, 2007, 94 (06) : 533 - 534
  • [9] Computational study on novel natural inhibitors targeting BCL2
    Lv, Xiaye
    Jiang, Yuting
    Wang, Xinhui
    Xie, HaoQun
    Dou, Gaojing
    Wang, Jing
    Yang, Wenzhuo
    Wang, Hongyu
    Li, Zijian
    Zhang, Xiangheng
    Chen, Zhenghe
    MEDICAL ONCOLOGY, 2021, 38 (08)
  • [10] Computational study on novel natural inhibitors targeting BCL2
    Xiaye Lv
    Yuting Jiang
    Xinhui Wang
    HaoQun Xie
    Gaojing Dou
    Jing Wang
    Wenzhuo Yang
    Hongyu Wang
    Zijian Li
    Xiangheng Zhang
    Zhenghe Chen
    Medical Oncology, 2021, 38
12345